Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-10-30 4:21 pm Unchanged | 13D | Cara Therapeutics Inc. CARA | Vifor (International) Ltd | 7,396,770 13.500% | 0 (Unchanged) | View |
2023-07-25 4:40 pm Unchanged | 13G | Cara Therapeutics Inc. CARA | Vifor (International) Ltd | 7,396,770 13.700% | 0 (Unchanged) | View |
2023-07-07 09:17 am Purchase | 13G | ELICIO THERAPEUTICS INC ELTX | Vifor (International) Ltd | 199,564 0.020% | 199,564 (New Position) | View |
2022-03-30 3:51 pm Purchase | 13G | ELICIO THERAPEUTICS INC ELTX | Vifor (International) Ltd | 1,995,643 6.700% | 1,995,643 (New Position) | View |
2021-10-21 4:15 pm Purchase | 13G | Cara Therapeutics Inc. CARA | Vifor (International) Ltd | 7,396,770 13.900% | 3,282,391 (+79.78%) | View |
2021-10-13 6:54 pm Sale | 13D | ChemoCentryx Inc. CCXI | Vifor (International) Ltd | 5,194,085 7.400% | -4,089,660 (-44.05%) | View |
2020-10-23 4:05 pm Purchase | 13G | Cara Therapeutics Inc. CARA | Vifor (International) Ltd | 4,114,379 8.300% | 4,114,379 (New Position) | View |
2020-07-31 4:54 pm Sale | 13D | ChemoCentryx Inc. CCXI | Vifor (International) Ltd | 9,283,745 13.700% | -693,378 (-6.95%) | View |
2020-07-16 07:56 am Sale | 13D | ChemoCentryx Inc. CCXI | Vifor (International) Ltd | 9,977,123 14.700% | -699,702 (-6.55%) | View |